Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrine Top Hartmann

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Ebiomedicine|February 21, 2025
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infectionKatharina Wørzner, Signe Tandrup Schmidt, Julie Zimmermann, et al.
Iscience|January 16, 2023
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animalsAnna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Ebiomedicine|September 10, 2022
Protection against SARS-CoV-2 transmission by a parenteral prime-Intranasal boost vaccine strategyDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
Ebiomedicine|February 21, 2025
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infectionKatharina Wørzner, Signe Tandrup Schmidt, Julie Zimmermann, et al.
Iscience|January 16, 2023
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animalsAnna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, et al.
Pageof 2